Anthony (tony) Hall BSc, MBBS

Tony is an experienced pharmaceutical physician with knowledge spanning a broad range of disciplines and therapy areas. Having founded and built his own successful company, he have a demonstrated ability to lead, inspire and motivate, together with keen strategic vision and commercial acumen.
From 2010 – 2014, he worked as a consultant exclusively on Orphan drugs and became heavily involved with all facets of the rare diseases community, regularly speaking at conferences. He have built trusted relationships with stakeholders at many different levels, including patient groups, key opinion leaders and academics. He have gained significant experience in drug development for orphan drugs, from understanding the special regulatory requirements applicable for orphan drugs to designing the clinical programs to meet them.
He was very interested in clinical endpoint development, including surrogate endpoints and in innovative drug development pathways, such as adaptive licensing with the involvement of all stakeholders, including payers at an early stage.